Costs in China($)
|
Monthly cost of sorafenib and TACE
|
Full-dose Sorafenib
|
The first 3 months without supportive policy48
|
7600.38
|
3800.19–15,200.76
|
3 months after48
|
15.06
|
7.53–30.11
|
Dose-adjusted Sorafenib
|
The first 3 months without supportive policy48
|
3807.72
|
1903.86–7615.43
|
3 months after48
|
15.06
|
8.03–32.11
|
TACE per session
|
3347.97
|
1673.99.23–6695.95
|
Monthly cost of progressive HCC#
|
247.43
|
123.71–494.86
|
Monthly cost of decompensated cirrhosisa,b
|
1131.82
|
565.91–2263.65
|
Monthly cost of compensated cirrhosisa,b
|
344.14
|
172.07–688.29
|
Costs in the USA($)
|
Monthly cost of sorafenib and TACE
|
Full-dose Sorafenib
|
The first 3 months without supportive policy50
|
4592.4
|
2296.2–9184.8
|
3 months after50
|
1.2
|
0.60–2.40
|
Dose-adjusted Sorafenib
|
The first 3 months without supportive policy50
|
2296.2
|
1148.10–4592.40
|
3 months after50
|
1.2
|
0.60–2.40
|
TACE per session49
|
25,961.00
|
12,980.50–51,922.0
|
Monthly cost of progressive HCC51#
|
8072
|
4036.00–16,144.00
|
Monthly cost of decompensated cirrhosis49#
|
1519.0
|
759.50–3038.00
|
Monthly cost of compensated cirrhosis49#
|
61.0
|
30.0–122.00
|